Brain-derived Neurotrophic Factor and High Sensitive C-reactive Protein in Bipolar Depression and Unipolar Depression: The Practical Usage as a Discriminatory Tool

키워드

참고문헌 (56)

1. Clemente AS, "Bipolar disorder prevalence : a systematic review and meta-analysis of the literature", Braz J Psychiatry, 37, pp.155~161 (2015)
2. Ferrari AJ, "Global variation in the prevalence and incidence of major depressive disorder : a systematic review of the epidemiological literature", Psychol Med, 43, pp.471~481 (2013)
3. Cloutier M, "The economic burden of bipolar I disorder in the United States in 2015", J Affect Disord, 226, pp.45~51 (2018)
4. Greenberg PE, "The economic burden of adults with major depressive disorder in the United States(2005 and 2010)", J Clin Psychiatry, 76, pp.155~162 (2015)
5. Fernandes BS, "Serum brain-derived neurotrophic factor in bipolar and unipolar depression : a potential adjunctive tool for differential diagnosis", J Psychiatr Res, 43, pp.1200~1204 (2009)
6. de Oliveira GS, "Decreased brain-derived neurotrophic factor in medicated and drug-free bipolar patients", J Psychiatr Res, 43, pp.1171~1174 (2009)
7. Murray ML, "Effects of the Committee on Safety of Medicines advice on antidepressant prescribing to children and adolescents in the UK", Drug Saf, 28, pp.1151~1157 (2005)
8. Perlis RH, "Association between bipolar spectrum features and treatment outcomes in outpatients with major depressive disorder", Arch Gen Psychiatry, 68, pp.351~360 (2011)
9. van Praag HM, "Why has the antidepressant era not shown a significant drop in suicide rates?", Crisis, 23, pp.77~82 (2002)
10. Baldessarini RJ, "Bipolar depression : a major unsolved challenge", Int J Bipolar Disord, 8, pp.1~ (2020)
11. Strawbridge R, "Biomarkers for depression : recent insights, current challenges and future prospects", Neuropsychiatr Dis Treat, 13, pp.1245~1262 (2017)
12. Skibinska M, "Elevated epidermal growth factor(EGF)as candidate biomarker of mood disorders-longitudinal study in adolescent and young adult patients", J Clin Med, 10, pp.4064~ (2021)
13. Lee HY, "Major depressive disorder: cognitive and neurobiological mechanisms" (2015), IntechOpen
14. Sahil Malik, "Biomarkers of Major Depressive Disorder: Knowing is Half the Battle", Clinical Psychopharmacology and Neuroscience, 19(1), pp.12~25 (2021), 대한정신약물학회[DOI]
15. Paola Rampelotto Ziani, "Potential Candidates for Biomarkers in Bipolar Disorder: A Proteomic Approach through Systems Biology", Clinical Psychopharmacology and Neuroscience, 20(2), pp.211~227 (2022), 대한정신약물학회[DOI]
16. Post RM, "Role of BDNF in bipolar and unipolar disorder : clinical and theoretical implications", J Psychiatr Res, 41, pp.979~990 (2007)
17. Cassiman D, "Human and rat hepatic stellate cells express neurotrophins and neurotrophin receptors", Hepatology, 33, pp.148~158 (2001)
18. Gray JD, "Dynamic plasticity : the role of glucocorticoids, brain-derived neurotrophic factor and other trophic factors", Neuroscience, 239, pp.214~227 (2013)
19. Weinstein G, "Serum brain-derived neurotrophic factor and the risk for dementia : the Framingham Heart Study", JAMA Neurol, 71, pp.55~61 (2014)
20. Martinowich K, "Interaction between BDNF and serotonin : role in mood disorders", Neuropsychopharmacology, 33, pp.73~83 (2008)
21. Cunha AB, "Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes", Neurosci Lett, 398, pp.215~219 (2006)
22. Gama CS, "Serum levels of brain-derived neurotrophic factor in patients with schizophrenia and bipolar disorder", Neurosci Lett, 420, pp.45~48 (2007)
23. Monteleone P, "Decreased levels of serum brain-derived neurotrophic factor in both depressed and euthymic patients with unipolar depression and in euthymic patients with bipolar I and II disorders", Bipolar Disord, 10, pp.95~100 (2008)
24. Sen S, "Serum brain-derived neurotrophic factor, depression, and antidepressant medications : meta-analyses and implications", Biol Psychiatry, 64, pp.527~532 (2008)
25. Brunoni AR, "A systematic review and metaanalysis of clinical studies on major depression and BDNF levels : implications for the role of neuroplasticity in depression", Int J Neuropsychopharmacol, 11, pp.1169~1180 (2008)
26. Kelleher RJ 3rd, "Translational regulatory mechanisms in persistent forms of synaptic plasticity", Neuron, 44, pp.59~73 (2004)
27. Jialal I, "C-reactive protein : risk marker or mediator in atherothrombosis?", Hypertension, 44, pp.6~11 (2004)
28. Kuta AE, "C-reactive protein is produced by a small number of normal human peripheral blood lymphocytes", J Exp Med, 164, pp.321~326 (1986)
29. Dickerson F, "Elevated C-reactive protein and cognitive deficits in individuals with bipolar disorder", J Affect Disord, 150, pp.456~459 (2013)
30. Koosha P, "High sensitivity C-reactive protein predictive value for cardiovascular disease : a nested case control from Isfahan Cohort Study(ICS)", Glob Heart, 15, pp.3~ (2020)
31. Liu Y, "Association between C-reactive protein and depression : modulated by gender and mediated by body weight", Psychiatry Res, 219, pp.103~108 (2014)
32. Huang TL, "High-sensitivity C-reactive protein levels in patients with major depressive disorder and bipolar mania", Prog Neuropsychopharmacol Biol Psychiatry, 31, pp.370~372 (2007)
33. Swaab DF, "The stress system in the human brain in depression and neurodegeneration", Ageing Res Rev, 4, pp.141~194 (2005)
34. Chiou YJ, "Brain-derived neurotrophic factor(BDNF)and bipolar disorder", Psychiatry Res, 274, pp.395~399 (2019)
35. Chang HH, "C-reactive protein : a differential biomarker for major depressive disorder and bipolar II disorder", World J Biol Psychiatry, 18, pp.63~70 (2017)
36. American Psychiatric Association, "Diagnostic and statistical manual of mental disorders : DSM-5" (2013), American Psychiatric Association
37. Ghassemzadeh H, "Psychometric properties of a Persian-language version of the Beck Depression Inventory--second edition : BDI-II-PERSIAN", Depress Anxiety, 21, pp.185~192 (2005)
38. Hossein Kaviani H, "Psychometric properties of the Persian version of Beck Anxiety Inventory(BAI)", Tehran Univ Med J, 66, pp.136~140 (2008)
39. Elfving B, "Depression, the Val66Met polymorphism, age, and gender influence the serum BDNF level", J Psychiatr Res, 46, pp.1118~1125 (2012)
40. Soares AT, "Decreased brain-derived neurotrophic factor in older adults with bipolar disorder", Am J Geriatr Psychiatry, 24, pp.596~601 (2016)
41. Wu YS, "Associations between serum brain-derived neurotrophic factors and bipolar disorder", Neuropsychiatry, 7, pp.968~973 (2017)
42. Fernandes BS, "Brain-derived neurotrophic factor as a statemarker of mood episodes in bipolar disorders : a systematic review and meta-regression analysis", J Psychiatr Res, 45, pp.995~1004 (2011)
43. Karege F, "Decreased serum brain-derived neurotrophic factor levels in major depressed patients", Psychiatry Res, 109, pp.143~148 (2002)
44. Jeenger J, "C-reactive protein, brain-derived neurotrophic factor, interleukin-2, and stressful life events in drug-naive first-episode and recurrent depression : a cross-sectional study", Indian J Psychiatry, 60, pp.334~339 (2018)
45. Li Z, "Brain-derived neurotrophic factor levels and bipolar disorder in patients in their first depressive episode : 3-year prospective longitudinal study", Br J Psychiatry, 205, pp.29~35 (2014)
46. Kunugi H, "Interface between hypothalamic-pituitary-adrenal axis and brain-derived neurotrophic factor in depression", Psychiatry Clin Neurosci, 64, pp.447~459 (2010)
47. Hashimoto K, "A BDNF Val66Met polymorphism and ketamine-induced rapid antidepressant action", Clin Psychopharmacol Neurosci, 10, pp.59~60 (2012)
48. Yu H, "The role of BDNF in depression on the basis of its location in the neural circuitry", Acta Pharmacol Sin, 32, pp.3~11 (2011)
49. Sjahrir M, "Correlation between serum brain-derived neurotrophic factor level and depression severity in psoriasis vulgaris patients", Open Access Maced J Med Sci, 7, pp.583~586 (2019)
50. Ma Y, "Association between depression and C-reactive protein", Cardiol Res Pract, 2011, pp.286509~ (2010)
51. Evers AK, "C-reactive protein concentration in bipolar disorder : association with genetic variants", Int J Bipolar Disord, 7, pp.26~ (2019)
52. Giese M, "BDNF : an indicator of insomnia?", Mol Psychiatry, 19, pp.151~152 (2014)
53. Molendijk ML, "Serum BDNF concentrations show strong seasonal variation and correlations with the amount of ambient sunlight", PLoS One, 7, pp.e48046~ (2012)
54. Hye Ji Min, "Association of the Brain-derived Neurotrophic Factor Gene and Clinical Features of Bipolar Disorder in Korea", Clinical Psychopharmacology and Neuroscience, 10(3), pp.163~167 (2012), 대한정신약물학회
55. Neves-Pereira M, "The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder : evidence from a family-based association study", Am J Hum Genet, 71, pp.651~655 (2002)
56. Sklar P, "Family-based association study of 76 candidate genes in bipolar disorder : BDNF is a potential risk locus. Brain-derived neutrophic factor", Mol Psychiatry, 7, pp.579~593 (2002)

관련 논문AI추천